Region: US
Website: wmgtech.com
Employees: 76
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:
wound management technologies, inc., through its subsidiary, wound care innovations, llc, distributes collagen-based wound care products in the united states. the company holds worldwide license to certain technologies and processes related to a collagen-based wound care product formulation under the brand name celleraterx. it markets celleraterx for pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns, and superficial wounds. the company offers celleraterx in gel and powder forms. it serves healthcare providers, such as physicians, clinics, and hospitals. wound management technologies was formerly known as mb software corporation. the company was founded in 1982 and is based in fort worth, texas.